Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion type Assertion NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_head.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion description "[A meta-analysis of 4,245 case and 5,982 control subjects indicated a null association of C282Y with diabetes risk, whereas carriers of H63D or the compound heterozygotes had marginally increased risk (odds ratio [OR] 1.11 [95% CI 1.00-1.25] and 1.60 [0.99-2.60], respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_provenance.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion evidence source_evidence_literature NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_provenance.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion SIO_000772 16306377 NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_provenance.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion wasDerivedFrom befree-2016 NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_provenance.
- NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_assertion wasGeneratedBy ECO_0000203 NP523838.RAHCBjrKL5JNE1tJowwBn7jz4Injslzid923J6MhiyfpE130_provenance.